We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other best performing growth ...

Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License ...

JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zai Lab (ZLAB – Research Report), Perspective ...

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has ...

Zai Lab Limited (NASDAQ:ZLAB) is a biopharmaceutical company that discovers, develops, and sells medicines. The company aims to address unmet medical needs in areas like cancer, autoimmune ...

Zai Lab Limited Unsponsored ADR (ZLAB) shares soared 9% in the last trading session to close at $33.78. The move was backed by solid volume with far more shares changing hands than in a normal ...

Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Zai Lab Limited - Depositary Receipt () (NasdaqGM:ZLAB) with a Sector Outperform recommendation. As of March 4, 2025 ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.